p75 neurotrophin receptor modulation in mild to moderate Alzheimer disease: a randomized, placebo-controlled phase 2a trial
Article in Nature Medicine (May 2024)
The most recent citing publications are shown below. View all 17 publications that cite this research output on Dimensions.
Machine Learning Approach to Identify Case-Control Studies on ApoE Gene Mutations Linked to Alzheimer’s Disease in Italy
Article in BioMedInformatics (February 2024)
The Nerve Growth Factor Receptor (NGFR/p75NTR): A Major Player in Alzheimer’s Disease
Article in International Journal of Molecular Sciences (February 2023)